V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159438 | 20061229 | 1.81 | 57.9 | Palliative (P) | 2017-01-31 | 2017-02-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101543886 |
| 20159439 | 20061230 | 1.88 | 53 | Adjuvant (A) | 2016-05-09 | 2016-05-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101021019 |
| 20159441 | 20061231 | null | null | Neo-adjuvant (N) | 2019-04-07 | 2019-04-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100874428 |
| 20159445 | 20061232 | 1.69 | 66.8 | Adjuvant (A) | 2017-05-06 | 2017-05-29 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101361239 |
| 20159446 | 20061233 | 1.65 | 49.6 | Neo-adjuvant (N) | 2019-04-01 | 2019-04-01 | ECX | 02 | Y | ECX | 100249267 |
| 20159448 | 20061234 | 1.75 | 89 | Palliative (P) | 2019-08-22 | 2019-09-11 | ECX | N | N | ECX | 101871344 |
| 20159451 | 20061235 | 1.76 | 51 | Palliative (P) | 2019-10-07 | 2019-10-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101396391 |
| 20159452 | 20061236 | 1.85 | 73.1 | Palliative (P) | 2017-03-05 | 2017-04-05 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101074600 |
| 20159453 | 20061237 | 1.72 | 86 | Palliative (P) | 2017-02-02 | 2017-02-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101295891 |
| 20159454 | 20061238 | 1.76 | 51.7 | Neo-adjuvant (N) | 2019-01-29 | 2019-01-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101125897 |
| 20159455 | 20061239 | 1.61 | 74.6 | Adjuvant (A) | 2017-04-16 | 2017-04-16 | ECX | N | N | ECX | 101455168 |
| 20159456 | 20061240 | 1.79 | 58.2 | Adjuvant (A) | 2016-04-10 | 2016-04-18 | ECX | N | N | ECX | 100372157 |
| 20159459 | 20061241 | 1.66 | 53.9 | Palliative (P) | 2017-08-18 | 2017-08-30 | ECX | N | N | ECX | 100197205 |
| 20159461 | 20061242 | 1.73 | 58.4 | Adjuvant (A) | null | 2017-12-11 | ECX | null | N | ECX | 100227015 |
| 20159462 | 20061243 | 1.8 | 73.45 | Palliative (P) | 2019-12-05 | 2019-12-13 | ECX | 2 | N | ECX | 101689974 |
| 20159466 | 20061244 | 1.52 | 64.8 | Neo-adjuvant (N) | 2019-01-07 | 2019-01-21 | ECX | N | N | ECX | 101033222 |
| 20159468 | 20061245 | 1.79 | 42.7 | Neo-adjuvant (N) | 2019-07-10 | 2019-07-31 | ECX | N | null | ECX | 101390880 |
| 20159470 | 20061246 | 1.85 | 77 | Adjuvant (A) | 2019-12-06 | 2019-12-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101675010 |
| 20159472 | 20061247 | 1.63 | 49.9 | Neo-adjuvant (N) | 2017-10-28 | 2017-11-09 | ECX | N | N | ECX | 101149737 |
| 20159473 | 20061248 | 1.7 | 97.7 | null | 2019-04-09 | 2019-04-27 | ECX | N | null | CAPECITABINE + GEMCITABINE | 100326728 |
| 20159475 | 20061249 | 1.57 | 61 | Curative (C) | 2018-04-17 | 2018-04-19 | ECX | 02 | N | ECX | 101151885 |
| 20159476 | 20061250 | 1.61 | 84.5 | Neo-adjuvant (N) | 2018-07-30 | 2018-07-30 | ECX | 02 | N | ECX | 101518388 |
| 20159478 | 20061251 | 1.72 | 90 | Adjuvant (A) | 2018-04-07 | 2018-04-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100382126 |
| 20159479 | 20061252 | 1.68 | 58.8 | null | 2017-12-25 | 2018-01-07 | CAPECITABINE + GEMCITABINE | N | N | ECX | 100874636 |
| 20159480 | 20061253 | 1.63 | 61.2 | Neo-adjuvant (N) | 2016-12-29 | 2017-01-11 | ECX | N | N | ECX | 101233513 |
| 20159481 | 20061254 | 1.56 | 114.6 | Palliative (P) | 2016-07-13 | 2016-08-03 | ECX | N | N | ECX | 101209995 |
| 20159482 | 20061255 | 1.62 | 55.65 | Palliative (P) | 2018-12-15 | 2019-01-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101120328 |
| 20159483 | 20061256 | 1.42 | 100.9 | Adjuvant (A) | 2016-08-03 | 2016-08-08 | ECX | N | Y | ECX | 101472051 |
| 20159484 | 20061257 | 1.7 | 70.7 | null | 2018-08-22 | 2018-08-23 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101179740 |
| 20159485 | 20061258 | 1.66 | 127.3 | Neo-adjuvant (N) | 2017-05-01 | 2017-05-05 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101087041 |
| 20159487 | 20061259 | 1.65 | 63 | Neo-adjuvant (N) | null | 2019-06-03 | Gemcitabine + Capecitabine | N | N | ECX | 100790223 |
| 20159491 | 20061260 | 1.79 | 90.4 | Neo-adjuvant (N) | 2019-12-02 | 2019-12-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101242804 |
| 20159492 | 20061261 | null | 91 | Adjuvant (A) | 2019-09-10 | 2019-09-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100004583 |
| 20159494 | 20061262 | 1.63 | 53.3 | Adjuvant (A) | 2016-05-08 | 2016-05-17 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100742769 |
| 20159495 | 20061263 | 1.65 | 69.4 | Neo-adjuvant (N) | 2018-02-08 | 2018-02-22 | ECX | 02 | N | ECX | 100656982 |
| 20159497 | 20061264 | 1.77 | 77.5 | Neo-adjuvant (N) | 2016-05-19 | 2016-05-24 | ECX | 02 | N | ECX | 101313597 |
| 20159498 | 20061265 | 1.71 | 112.8 | Neo-adjuvant (N) | null | 2019-06-22 | Gemcitabine + Capecitabine | N | N | ECX | 100853298 |
| 20159500 | 20061266 | 1.49 | 51 | null | 2016-11-01 | 2016-11-14 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100339527 |
| 20159501 | 20061267 | 1.76 | 78.7 | Neo-adjuvant (N) | 2018-03-10 | 2018-03-11 | ECX | 02 | N | ECX | 101386784 |
| 20159503 | 20061268 | 1.68 | 78.5 | Neo-adjuvant (N) | 2017-01-27 | 2017-02-05 | ECX | 02 | N | ECX | 101849165 |
| 20159505 | 20061269 | 1.7 | 108 | Neo-adjuvant (N) | 2018-08-20 | 2018-08-27 | ECX | 2 | N | ECX | 100668454 |
| 20159506 | 20061270 | 1.81 | 74.9 | Palliative (P) | 2019-11-03 | 2019-11-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101063233 |
| 20159507 | 20061271 | 1.6 | 59.8 | Adjuvant (A) | 2016-08-30 | 2016-09-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101515547 |
| 20159508 | 20061272 | 1.79 | 121.4 | Curative (C) | 2016-11-12 | 2016-11-12 | ECX | N | N | ECX | 100843097 |
| 20159511 | 20061273 | 1.71 | 75.05 | Palliative (P) | null | 2018-07-08 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101755573 |
| 20159515 | 20061274 | 1.72 | 80.6 | Adjuvant (A) | 2016-06-20 | 2016-07-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100645324 |
| 20159516 | 20061275 | 1.62 | 75.8 | Adjuvant (A) | 2018-01-04 | 2018-01-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101571649 |
| 20159517 | 20061276 | 1.64 | 64.5 | null | 2016-03-17 | 2016-03-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100158580 |
| 20159518 | 20061277 | 1.67 | 80 | Neo-adjuvant (N) | 2016-08-16 | 2016-08-22 | ECX | null | N | ECX | 100353107 |
| 20159521 | 20061278 | 1.54 | 54.2 | Adjuvant (A) | 2019-07-29 | 2019-08-04 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100979229 |